SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genaissance Pharmaceuticals (GNSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (128)1/21/2003 2:51:44 PM
From: Findit  Read Replies (1) of 183
 
Ridgeland, MS, JAN 21, 2003 (EventX/Knobias.com via COMTEX) -- Company: Genaissance Pharmaceuticals, Inc. (NasdaqNM: GNSC)

Analyst Firm: Brean Murray

Rating Action: Coverage Reiterated

Rating: Buy

12-Month Target Price: $2

Source: Briefing.com

NOTE - I sold 75% of my position this morning at 1.39. Will buy in again if it recedes to the 1.15 area.

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News